Raleigh, NC, United States of America

Robert J Schotzinger

USPTO Granted Patents = 23 

 

 

Average Co-Inventor Count = 3.4

ph-index = 12

Forward Citations = 340(Granted Patents)


Company Filing History:


Years Active: 2012-2022

Loading Chart...
Loading Chart...
Loading Chart...
23 patents (USPTO):Explore Patents

Title: Robert J. Schotzinger: Innovator in Drug Development

Introduction

Robert J. Schotzinger is a prominent inventor based in Raleigh, NC, who holds an impressive portfolio of 23 patents. His innovative contributions primarily focus on developing compounds that have significant implications in the fields of biochemistry and pharmaceutical science. With a solid background working in leading pharmaceutical companies, Schotzinger has made a lasting impact on the industry.

Latest Patents

Among his latest patents is a groundbreaking invention related to metalloenzyme inhibitor compounds. This invention describes compounds that exhibit metalloenzyme modulating activity and outlines methods to treat various diseases, disorders, or symptoms that are mediated by such metalloenzymes. Additionally, Schotzinger has developed antifungal compounds defined by a specific chemical formula. These compounds act as inhibitors of essential metalloenzymes, such as lanosterol demethylase (CYP51), showcasing his dedication to advancing therapeutic strategies.

Career Highlights

Throughout his career, Schotzinger has contributed his expertise to renowned firms in the pharmaceutical industry, including Viamet Pharmaceuticals and Mycovia Pharmaceuticals. His work has positioned him as a notable figure within the realm of pharmaceutical inventions, driving forward innovative solutions to complex health challenges.

Collaborations

Robert has collaborated with various distinguished professionals in the field, including William Joel Hoekstra and Stephen William Rafferty. These collaborations reflect his commitment to fostering innovation and enhancing the development of new therapeutic agents.

Conclusion

Robert J. Schotzinger continues to be a significant force in the pharmaceutical landscape, leveraging his extensive patent portfolio to influence drug development and treatment methodologies. His contributions not only demonstrate his expertise but also highlight the transformative potential of innovations within the healthcare sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…